Research Laboratory Services Tender

Research Laboratory Services Tender

Provision of Vascular Endothelial Cells from Human Embryonic Stem Cells at GMP Quality.

UK-Glasgow: Research laboratory services

2013/S 011-014029

Contract notice


Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

University of Glasgow
Purchasing Office, Level 4, Gilbert Scott Building, University Avenue
Contact point(s): Please make contact through the Public Contracts site to the contact as follows:
For the attention of: Claire McCallum Quoting Ref: PURCH0849 PQQ
G12 8QQ Glasgow
Telephone: +44 1413303216
Fax: +44 1413303717

Internet address(es):

General address of the contracting authority: http:\\
Address of the buyer profile:

Further information can be obtained from: The above mentioned contact point(s)

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: PQQ documents available from Public Contracts Scotland
PQQ documents available from Public Contracts Scotland
For the attention of: .
Telephone: +44 1410000000
Fax: +44 1410000000
Internet address:

Tenders or requests to participate must be sent to: PQQ documents to be returned via Public Contracts Scotland http://www.publiccontractsscotland.go
PQQ documents to be returned via Public Contracts Scotland
For the attention of: .
Telephone: +44 1410000000
Fax: +44 1410000000
Internet address:

I.2)Type of the contracting authority
Body governed by public law
I.3)Main activity
I.4)Contract award on behalf of other contracting authorities
The contracting authority is purchasing on behalf of other contracting authorities: no

Section II: Object of the contract

II.1.1)Title attributed to the contract by the contracting authority:
PURCH/0849 Provision of Vascular Endothelial Cells from Human Embryonic Stem Cells at GMP Quality.
II.1.2)Type of contract and location of works, place of delivery or of performance
Main site or location of works, place of delivery or of performance: Glasgow, Edinburgh, Bristol.
NUTS code UK
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves a public contract
II.1.4)Information on framework agreement
II.1.5)Short description of the contract or purchase(s)
PURCH/0849 Provision of Vascular Endothelial Cells from Human Embryonic Stem Cells at GMP Quality.
Prequalification Questionnaire documents available from Public Contracts Scotland.
Prequalification Questionnaire documents returns should be submitted via Public Contracts, no paper copies will be accepted. Should paper tenders be submitted, they will be rejected. Further to this any questions or communications regarding individual tender exercises must be sent via the Public Contracts Scotland Portal. Tender queries received through any other channel will not be answered. Should users of Public Contracts Scotland have any problems with the web site they should contact website Support Desk, contact details can be found by following the ‘Contact Us’ option on the left hand menu at

NOTE: To register your interest in this notice and obtain any additional information please visit the Public Contracts Scotland Web Site at

The awarding authority has indicated that it will accept electronic responses to this notice via a ‘Tender Submission Postbox’ facility. Further details of this facility are available at

Suppliers are advised to allow adequate time for uploading documents and to dispatch the electronic response well in advance of the closing time to avoid any last minute problems. The postbox closes precisely at the time stated.

II.1.6)Common procurement vocabulary (CPV)

73111000, 71900000

II.1.7)Information about Government Procurement Agreement (GPA)
The contract is covered by the Government Procurement Agreement (GPA): yes
This contract is divided into lots: no
II.1.9)Information about variants
Variants will be accepted: no
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:
II.2.2)Information about options
Options: no
II.2.3)Information about renewals
This contract is subject to renewal: no
II.3)Duration of the contract or time limit for completion

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:
Joint and several liability.
III.1.4)Other particular conditions
The performance of the contract is subject to particular conditions: yes
Description of particular conditions: All Participants please see the Requirement Specification attached as additional information at: PURCH0849 PQQ Additional Information.pdf.
All information requested in this questionnaire is mandatory. Failure to supply information will result in exclusion. Inability to meet mandatory requirements will result in exclusion. Mandatory eligibility criteria for inclusion into this exercise:-
a) Previous experience of collaborating with Higher Education (HE) university organisations to deliver human embryonic derived cell therapy products b) Possession and immediate availability for the project of at least 3 human embryonic lines that have been derived at GMP grade for potential clinical use c) Have worked with vascular endothelial cells in the recent (24 month) past d) Provide evidence of experience in translating research protocols for stem cell differentiation to GMP-compliant SOPs.
Provide copies of the CV’s of the individual who, in the event of a successful tender, will lead the team and be responsible for overseeing the team’s work and also provide copies of the CV’s of each member of the team. The team leader and each member of the team must as a minimum demonstrate experience in delivering materials for cell therapy products.
Copy certification for (or written undertaking to provide) Professional Indemnity insurance of at least 2M GBP. Tenderer must be able to demonstrate that all subcontractors used will also hold Professional Indemnity insurance, as a minimum, 1M GBP.
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers
III.2.2)Economic and financial ability
III.2.3)Technical capacity
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession
III.3.2)Staff responsible for the execution of the service

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure
Accelerated restricted
Justification for the choice of accelerated procedure: The University project will last 3 years however the cell production needs to be finalized urgently within the first 12 months of grant award, therefore the University now urgently needs to engage a commercial partner to begin developing the protocols required. The timescales for delivery of the Project mean that it is impractical to comply with the longer procurement timescales for using a restricted OJEU procedure and the University is therefore using the accelerated timescales provided for in Regulation 16 of The Public Contracts (Scotland) Regulations 2012.
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate
Envisaged minimum number 5
IV.1.3)Reduction of the number of operators during the negotiation or dialogue
IV.2)Award criteria
IV.2.1)Award criteria

The most economically advantageous tender in terms of the criteria stated below

1. Price.. Weighting 25

2. Ability to scale cell production for production of final cell amounts.. Weighting 20

3. Production of human endothelial cells from embryonic stem cells.. Weighting 20

4. Ability to deliver live cells to partners (Glasgow, Edinburgh, Bristol) within 8 hours.. Weighting 15

5. Ability to undertake cell therapy research involving human embryonic (hES) stem cells.. Weighting 10

6. Availability of draft protocol as a start point for protocol development.. Weighting 10

IV.2.2)Information about electronic auction
An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:
IV.3.2)Previous publication(s) concerning the same contract
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document
IV.3.4)Time limit for receipt of tenders or requests to participate
23.1.2013 – 12:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening of tenders

Section VI: Complementary information

VI.1)Information about recurrence
VI.2)Information about European Union funds
VI.3)Additional information
Submissions can be created and submitted up to the stated tender deadline. Once the deadline has passed submissions can neither be created nor submitted. It is not advisable for Suppliers to wait until the last moment before creating and dispatching a response in case of any last minute problems. Please note large files should be uploaded as early as possible to ensure transfer before deadline. If a Supplier is having problems uploading to the PCS site, then the University must be informed well in advance and depending upon the merit of the case, the University may arrange for the tender to remain open on the PCS system for a short period after the deadline time stated. System problems do not fall under the University’s remit and should be referred to PCS.
Postbox Security: Postbox submissions cannot be accessed by anyone, including Millstream, (the provider of the Public Contracts Scotland system) until the deadline.
Suppliers should note that when asked to complete a tender document, the document must be submitted in the file type in which it was issued (Word, Excel etc.). Files of any alternative type may only be used where documents are for attachment, rather than completion.
Freedom of Information
The Freedom of Information (Scotland) Act 2002, which came into force on 1 January 2005, designates University of Glasgow as a Scottish public authority and therefore subject to the provisions and obligations in that Act. This means that any person who makes a valid request for information held by University of Glasgow will be entitled to receive it, unless all or part of that information can be withheld by virtue of the exemptions in that Act.
As part of our responsibility under the Act, University of Glasgow may be required to disclose any information held relating to your response to anyone who makes a request under that Act. Such information may only be withheld if it meets one or more of the exemptions or conditions in that Act. Even if an exemption is available University of Glasgow may nevertheless disclose requested information. Information held cannot simply be classified as “confidential” or “commercial in confidence” to enable it to be protected from disclosure.
University of Glasgow may publish the names and contact details of companies who have been issued with a Questionnaire on its website.
Information may also be requested under the Data Protection Act 1998 and the Environmental Information (Scotland) Regulations 2004.
(SC Ref:250674)
VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures
VI.4.2)Lodging of appeals
VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:11.1.2013

Enjoyed this post? Share it!